Type 2 diabetes

Diabetes is a chronic disease related to dysfunction in the production or use of insulin, a hormone that regulates blood sugar. The gastrointestinal microbiota has been identified as one of the environmental factors that may be to blame.

Created 03 August 2021
Updated 17 September 2021

About this article

Created 03 August 2021
Updated 17 September 2021

In 2015, 415 million people had diabetes. According to WHO forecasts, it will be 642 million in 2040. Ninety percent of cases are type 2 diabetes.

Insulin resistance, the primary cause of type 2 diabetes

The primary cause of type 2 diabetes is cells in the body losing their sensitivity to insulin. This resistance to insulin makes the hormone ineffective and leads the pancreas to produce more, to the point of exhaustion. As a result, sugar accumulates in the blood, leading to hyperglycemia and serious long-term complications: myocardial infarction, stroke, arteritis in the lower limbs, kidney failure, and blindness. 

Involvement of the intestinal microbiota?

Although there is a genetic component to type 2 diabetes, lifestyle is the biggest risk factor for the disease--especially sedentism and a diet including too much fat and sugar. Certain fats and sugars set off an inflammatory response associated with metabolic disorders, which in turn increase the level of inflammation. It starts a vicious cycle, in which the gastrointestinal microbiota contributes because it is unbalanced. Researchers have shown that the gastrointestinal microbiota is disrupted in diabetics, and that this dysbiosis contributes to the disease. 

Lifestyle improvements

Above all, diabetes is treated by making lifestyle improvements: weight loss if necessary, regular physical activity, and a balanced diet. It is often necessary to add medication.
The role of certain intestinal bacteria and/or probiotics in diabetes has yet to be confirmed, but their beneficial effects (particularly on appetite and blood sugar) have opened a path for the development of new therapeutic targets for this disease, which affects millions of people.

  • IDF Diabetes Atlas http://www.diabetesatlas.org/
  • Diabète de type 2, Inserm, avril 2014 http://www.inserm.fr/thematiques/physiopathologie-metabolisme-nutrition/dossiers-d-information/diabete-de-type-2-dnid
  • Jin C, Henao-Mejia J, Flavell RA. Innate immune receptors : key regulators of metabolic disease progression. Cell Metab 2013 ; 17 : 873-82
  • Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007 ; 56 : 1761-72
  • Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007 ; 50 : 2374-83.
  • Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004 ; 101 : 15718-23.
  • Serino M, Luche E, Gres S, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut, BMJ Publishing Group, 2012 ; 61 : 543-53. https://hal.archives-ouvertes.fr/inserm-00726182/document
  • Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. Diet induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008 ; 3 : 213-23.

en_view en_sources